14465 results in Neurology and Clinical Neuroscience
6 - Artificial Intelligence in Alzheimer’s Drug Discovery
- from Section 1 - Advancing Alzheimer’s Disease Therapies in a Collaborative Science Ecosystem
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 62-72
-
- Chapter
- Export citation
38 - SPARKing Drug Development for Alzheimer’s Disease in Academia
- from Section 5 - Academic Drug-Development Programs
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 437-448
-
- Chapter
- Export citation
26 - Expanded Access and Compassionate Use in Alzheimer’s Disease Drug Development
- from Section 3 - Alzheimer’s Disease Clinical Trials
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 301-308
-
- Chapter
- Export citation
3 - Alzheimer’s Disease Drug Discovery in Academia: From High-Throughput Screening to In Vivo Testing
- from Section 1 - Advancing Alzheimer’s Disease Therapies in a Collaborative Science Ecosystem
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 34-44
-
- Chapter
- Export citation
Foreword
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp xix-xix
-
- Chapter
- Export citation
10 - Biobanking and Biomarkers in the Alzheimer’s Disease Drug-Development Ecosystem
- from Section 2 - Non-clinical Assessment of Alzheimer’s Disease Candidate Drugs
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 123-134
-
- Chapter
- Export citation
42 - Valley of Death and the Role of Venture Philanthropy in Alzheimer’s Disease Drug Development
- from Section 7 - Funding and Financing Alzheimer’s Disease Drug Development
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 480-485
-
- Chapter
- Export citation
Section 6 - Public–Private Partnerships in Alzheimer’s Disease Drug Development
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 455-464
-
- Chapter
- Export citation
25 - Tele-Trials, Remote Monitoring, and Trial Technology for Alzheimer’s Disease Clinical Trials
- from Section 3 - Alzheimer’s Disease Clinical Trials
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 292-300
-
- Chapter
- Export citation
21 - The Role of Online Registries in Accelerating Alzheimer’s Disease Drug Development
- from Section 3 - Alzheimer’s Disease Clinical Trials
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 257-265
-
- Chapter
- Export citation
20 - Alzheimer’s Disease Trial Recruitment and Diversifying Trial Populations
- from Section 3 - Alzheimer’s Disease Clinical Trials
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 249-256
-
- Chapter
- Export citation
44 - The Role of Philanthropy in Alzheimer’s Disease Therapeutic Development
- from Section 7 - Funding and Financing Alzheimer’s Disease Drug Development
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 496-502
-
- Chapter
- Export citation
48 - Federal Small Business Support for Small Businesses Pursuing Alzheimer’s Disease Drug Development
- from Section 7 - Funding and Financing Alzheimer’s Disease Drug Development
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 533-543
-
- Chapter
- Export citation
22 - Data Safety Monitoring Boards in Alzheimer’s Disease Trials
- from Section 3 - Alzheimer’s Disease Clinical Trials
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 266-274
-
- Chapter
- Export citation
17 - The Global Alzheimer’s Platform Foundation®: Delivering New Medicines Faster by Accelerating Clinical Trials
- from Section 3 - Alzheimer’s Disease Clinical Trials
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 207-215
-
- Chapter
- Export citation
16 - The European Prevention of Alzheimer’s Disease Program: A Public–Private Partnership to Facilitate the Secondary Prevention of Alzheimer’s Disease Dementia
- from Section 3 - Alzheimer’s Disease Clinical Trials
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 190-206
-
- Chapter
- Export citation
19 - Statistical Considerations in the Design and Analysis of Alzheimer’s Disease Clinical Trials
- from Section 3 - Alzheimer’s Disease Clinical Trials
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 232-248
-
- Chapter
- Export citation
1 - Alzheimer’s Disease Drug Development: A Research and Development Ecosystem
- from Section 1 - Advancing Alzheimer’s Disease Therapies in a Collaborative Science Ecosystem
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 1-24
-
- Chapter
- Export citation
45 - National Institute on Aging’s Alzheimer’s Disease Translational Research Program: Diversifying the Drug-Development Pipeline for the Treatment and Prevention of Alzheimer’s Disease and Related Dementias
- from Section 7 - Funding and Financing Alzheimer’s Disease Drug Development
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 503-512
-
- Chapter
- Export citation
4 - The Harrington Discovery Institute and Alzheimer’s Disease Drug Development
- from Section 1 - Advancing Alzheimer’s Disease Therapies in a Collaborative Science Ecosystem
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 45-53
-
- Chapter
- Export citation